Download citation file:
From the University of Washington and Veterans Affairs Puget Sound Health Care System, and Group Health Center for Health Studies, Seattle, Washington; Veterans Affairs Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts; and University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, California.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
Acknowledgment: The authors thank Drs. Bill Hazzard and Rudy Rodriguez for their insightful comments on several drafts of this manuscript.
Note: In-progress versions of this work were presented at the National Kidney Foundation Spring Clinical Meetings, Dallas, Texas, 2–6 April 2008, and the American Society of Nephrology–Association of Specialty Professors Workshop on Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults, Arlington, Virginia, 9–10 May 2008.
Grant Support: By a Beeson Career Development Award from the National Institute on Aging to Dr. O'Hare (K 1K23AG28980).
Potential Financial Conflicts of Interest:Grants received: A.M. O'Hare (Centers for Disease Control and Prevention), J.S. Kaufman (Department of Veterans Affairs, National Institutes of Health, Keryx, Proteon, Genzyme), K.E. Covinsky (National Institute on Aging, San Francisco Veterans Affairs Medical Center, University of California, San Francisco), C.S. Landefeld (National Institute on Aging, San Francisco Veterans Affairs Medical Center, University of California, San Francisco), E.B. Larson (National Institute on Aging, National Human Genome Research Institute, National Center for Research Resources, National Heart, Lung, and Blood Institute). Royalties: A.M. O'Hare (UpToDate), E.B Larson (UpToDate).
Requests for Single Reprints: Ann M. O'Hare, MD, Division of Nephrology, Department of Medicine, University of Washington and Veterans Affairs Puget Sound Health Care System, Nephrology and Renal Dialysis Unit, Building 100, Room 5B113, 1660 South Columbian Way, Seattle, WA 98108; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. O'Hare: Division of Nephrology, Department of Medicine, University of Washington and Veterans Affairs Puget Sound Health Care System, Nephrology and Renal Dialysis Unit, Building 100, Room 5B113, 1660 South Columbian Way, Seattle, WA 98108.
Dr. Kaufman: Veterans Affairs Boston Healthcare System and Boston University School of Medicine Renal Section (111-RE), 150 South Huntington Avenue, Boston, MA 02130.
Drs. Covinsky and Landefeld: University of California, San Francisco, San Francisco Veterans Affairs Medical Center, 4150 Clement Street (181G), San Francisco, CA 94121.
Dr. McFarland: Northwest Center for Outcomes Research in Older Adults, Veterans Affairs Puget Sound Health Care System (S-152), 1100 Olive Way, Suite 1400, Seattle, WA 98101.
Dr. Larson: Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101-1448.
Author Contributions: Conception and design: A.M. O'Hare, E.B. Larson.
Analysis and interpretation of the data: A.M. O'Hare, J.S. Kaufman, K.E. Covinsky, L.V. McFarland, E.B. Larson.
Drafting of the article: A.M. O'Hare, E.B. Larson.
Critical revision of the article for important intellectual content: A.M. O'Hare, J.S. Kaufman, K.E. Covinsky, C.S. Landefeld, L.V. McFarland, E.B. Larson.
Final approval of the article: A.M. O'Hare, J.S. Kaufman, K.E. Covinsky, C.S. Landefeld, L.V. McFarland, E.B. Larson.
Provision of study materials or patients: A.M. O'Hare.
Statistical expertise: A.M. O'Hare, J.S. Kaufman, L.V. McFarland, E.B. Larson.
Obtaining of funding: A.M. O'Hare.
Administrative, technical, or logistic support: A.M. O'Hare, E.B. Larson.
Collection and assembly of data: A.M. O'Hare.
Angiotensin-converting enzyme inhibitors and angiotensin IIâ€“receptor antagonists are recommended for patients with chronic kidney disease because these drugs can slow disease progression. Older adults account for a large and growing number of patients with chronic kidney disease. The authors evaluated the relevance to adults older than 70 years of the evidence base for major U.S. practice guidelines for the use of these agents in chronic kidney disease. The authors first examined the representation of older adults in randomized trials that underpin these guidelines, then compared the characteristics of participants in these trials with those of a representative sample of older adults with chronic kidney disease in the general population. The authors found that current guidelines for the use of angiotensin-converting enzyme inhibitors and angiotensin IIâ€“receptor antagonists in chronic kidney disease are based on evidence with limited relevance to most persons older than 70 years with this condition.
ACR = albumin–creatinine ratio; eGFR = estimated glomerular filtration rate.
Please read the other comments before posting. Contributors must reveal any conflict
Comments are moderated and will appear on the site at the discretion of The American
College of Physicians editorial staff. Please be sure your email address is
updated in your account, otherwise the American College of Physicians will not be
able to contact you about your comment.
Anyone can submit a comment any time after publication, but only those submitted within 4 weeks of an article’s publication will be considered for print publication. One month after publication, editors review all posted comments and select some for publication in the Letters section of the print version of Annals. (Not peer reviewed)
Authors: No more than 5
Text: Word Limit 400 (excludes references), 5 references, no figures or tables
* = Required Field
Disclosure of Any Conflicts of Interest*
(applies to the past 5 years and foreseeable future) Indicate any potential conflicts
of interest of each author below, including specific financial interests and relationships
and affiliations relevant to the subject matter or materials discussed in the manuscript
(eg, employment/affiliation, grants or funding, consultancies, honoraria, speakers
bureau, stock ownership or options, expert testimony, royalties, donation of medical
equipment, or patents filed, received, or pending). If all authors have none, check
"No potential conflicts or relevant financial interests" in the box below. Please
also indicate any funding received in support of this work. The information will
be posted with your response.
The In the Clinic® slide sets are owned and copyrighted by the American College
of Physicians (ACP). All text, graphics, trademarks, and other intellectual property
incorporated into the slide sets remain the sole and exclusive property of the ACP.
The slide sets may be used only by the person who downloads or purchases them and
only for the purpose of presenting them during not-for-profit educational activities.
Users may incorporate the entire slide set or selected individual slides into their
own teaching presentations but may not alter the content of the slides in any way
or remove the ACP copyright notice. Users may make print copies for use as hand-outs
for the audience the user is personally addressing but may not otherwise reproduce
or distribute the slides by any means or media, including but not limited to sending
them as e-mail attachments, posting them on Internet or Intranet sites, publishing
them in meeting proceedings, or making them available for sale or distribution in
any unauthorized form, without the express written permission of the ACP. Unauthorized
use of the In the Clinic slide sets will constitute copyright infringement.
to gain full access to the content and tools.
Learn more about subscription options